Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study.
CONCLUSIONS: The safety and effectiveness of chemotherapy with CD in a real-world setting were consistent with the results from a randomized controlled study. The different toxicity profiles between the 2 chemotherapy (CD and CP) regimens should be considered in the clinical practice.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03562533.
PMID: 31912673 [PubMed - as supplied by publisher]
Source: Journal of Gynecologic Oncology - Category: OBGYN Tags: J Gynecol Oncol Source Type: research
More News: Allergy & Immunology | Alopecia | Brain | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Neurology | Neurosurgery | OBGYN | Ovarian Cancer | Ovaries | Peripheral Neuropathy | Peritoneal Cancer | Study | Toxicology